Thanks for the heads up nilnoony. It’s a Good encouraging report as always but just a rehash of the same old . Authors comment about the revenues is probably the most truthful comment. Article does mention that 3 of the top 10 U.S hospitals are still trialing the 1a and a bit further down mentions that they expect 7 of the top 10 to be using it very soon so they are obviously very hopeful of converting the 3 hospital trials into future sales. As you know it’s already used in 4 of the top 10. I would be interested to know if successful how many is normal for a hospital to purchase. 1 or 10 etc . maybe I am just searching for positives.lol. I agree with muya - would love another space labs type of distribution agreement with someone. Whilst it was a longtime ago would like to know why it didn’t last long and what revenues it generated whilst it was active.
UCM Price at posting:
13.5¢ Sentiment: None Disclosure: Held
